Brief: Celldex Therapeutics Presents Positive Phase 2 Data For Barzolvolimab In CSU, ColdU, And SD
27/03/2026 15:24
March 27 (Reuters) - Celldex Therapeutics Inc CLDX.O: CELLDEX THERAPEUTICS INC - PRESENTS POSITIVE PHASE 2 DATA FOR BARZOLVOLIMAB IN CSU, COLDU, AND SD Source text: ID:nGNX2k1xqf Further company coverage: CLDX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Celldex Therapeutics
See all newsUS RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
U.S. STOCKS ON THE MOVE-Greenland Mines, GameStop, Shopify
Celldex shares slip as safety concerns cloud skin drug trial win (updated)
Celldex falls after two probable anaphylaxis cases in trials
Celldex's skin disease drug meets goals in two late-stage trials